Available datapackage for study 'A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Subjects With Active Psoriatic Arthritis'

The primary purpose of this study is to evaluate the efficacy of guselkumab treatment in
participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and
symptoms of PsA.